Continuous-Flow Synthesis of Bedaquiline via Low-Temperature Reactors

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing bedaquiline suffer from low yield, long production time, high cost, complicated operation, and safety hazards due to the use of active lithium reagents, making it challenging to produce the drug efficiently and affordably for low-income populations.

Innovation Solution

A low-temperature continuous-flow method is developed, involving specific feed liquids and reactions in continuous flow reactors to produce bedaquiline, which simplifies the synthesis, enhances yield, and improves safety by eliminating the need for hazardous reagents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional batch reaction process is used with lithium reagents, then bedaquiline can be synthesized, but the process suffers from safety hazards, long reaction time, and complicated operation

Engineering Contradiction:
ImprovesafetyVSAvoidreaction time
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent replaces traditional batch mechanical reaction processes with continuous flow chemistry technology. The continuous flow reactor system substitutes manual batch operations with automated fluid dynamics-based reaction control, eliminating safety hazards associated with lithium reagents while reducing reaction time from hours to minutes through enhanced mass and heat transfer efficiency

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes critical reaction parameters by implementing continuous flow conditions with precise temperature control (low temperature conditions) and optimized residence time. The continuous flow system allows for parameter optimization including flow rates, temperature gradients, and reactant concentration ratios, transforming the reaction from a lengthy batch process to a rapid continuous process with improved safety profile

Inventive Principle:
Principle #35Parameter changes

2Productivity

If existing synthesis methods are used, then bedaquiline is produced, but the yield is low and production cost is high

Engineering Contradiction:
ImproveyieldVSAvoidproduction cost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent implements continuous flow chemistry to replace discontinuous batch processing. The continuous reaction system maintains steady-state conditions throughout the reaction process, eliminating idle times between batches and enabling continuous product formation. This continuity increases overall yield by maximizing reaction efficiency and allows for scalable production that reduces per-unit manufacturing costs

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent employs preliminary action by pre-mixing reactants in specific ratios and conditions before they enter the reaction zone. The continuous flow system allows for precise pre-mixing and pre-conditioning of reactant streams, ensuring optimal reaction conditions are established before the actual reaction occurs, thereby maximizing yield and reducing waste that would increase production costs

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If conventional synthesis routes are employed, then bedaquiline can be obtained, but the operation is complicated and purity requires extensive post-processing

Engineering Contradiction:
ImprovepurityVSAvoidoperational complexity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent applies extraction principles by removing the need for complex post-processing purification steps through the continuous flow reaction design. The optimized continuous reaction conditions produce highly selective reactions that minimize byproduct formation, effectively extracting the purification requirement from the overall process. The system takes out the complicated column chromatography and multiple filtration steps that characterize conventional synthesis routes

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The continuous flow system provides self-service purification through integrated reaction conditions that inherently favor product formation with minimal impurities. The precise control of reaction parameters in the continuous flow reactor creates self-purifying conditions where the reaction selectively produces the desired product, eliminating the need for extensive external purification operations and simplifying the overall operational complexity

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high purity (>99.8%) bedaquiline with a significantly shorter production cycle, reducing costs and operational complexity, making it suitable for industrial production.

Implementation Method 1

involving specific feed liquids and reactions in continuous flow reactors to produce bedaquiline

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Data Source

PatentUS12116345B2Low-temperature continuous-flow preparation method of bedaquiline
Publication Date: 2024.10.15 SPH NO 1 BIOCHEM & PHARMA CO LTD
  • US12116345B2 patent drawing
  • US12116345B2 patent drawing
  • US12116345B2 patent drawing

AI summary

A low-temperature continuous-flow preparation method of bedaquiline includes the following steps. (a) A first feed liquid and a second feed liquid are subjected to a first continuous flow reaction for 30-600 seconds to obtain a first reaction mixture. (b) The first reaction mixture and a third feed liquid are subjected to a second continuous flow reaction for 30-600 seconds to obtain a second reaction mixture. (c) The second reaction mixture was quenched to afford bedaquiline.